Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Saccharum Lactis
Generic Name
Saccharum Lactis
Active Ingredient
Lactose, Unspecified FormCategory
Vitamin C [EPC]
Variants
8
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 1 [hp_M]/1 | PELLET | ORAL | 37662-1418 |
| 100 [hp_C]/1 | PELLET | ORAL | 37662-1415 |
| 6 [hp_C]/1 | PELLET | ORAL | 37662-1412 |
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Saccharum Lactis, you must consult a qualified healthcare professional.
| 200 [hp_C]/1 | PELLET | ORAL | 37662-1416 |
| 30 [hp_C]/1 | PELLET | ORAL | 37662-1414 |
| 1 [hp_Q]/1 | PELLET | ORAL | 37662-1419 |
| 12 [hp_C]/1 | PELLET | ORAL | 37662-1413 |
| 500 [hp_C]/1 | PELLET | ORAL | 37662-1417 |
Detailed information about Saccharum Lactis
Lactose, Unspecified Form is a multi-functional pharmaceutical agent used in diagnostic testing, allergen immunotherapy, and as a metabolic modulator in specific clinical settings.
The dosage of Lactose, Unspecified Form, is highly individualized and depends entirely on the condition being treated.
Pediatric use must be approached with extreme caution.
Patients with impaired kidney function (reduced GFR) may require significant dose reductions, particularly when the agent is used for nitrogen binding. Accumulation of the drug can lead to increased toxicity and electrolyte imbalances. Monitoring of creatinine clearance is mandatory.
Since many of the active components (methylxanthines, steroids) are metabolized in the liver, patients with cirrhosis or hepatitis may experience prolonged half-lives. Dose reductions of 25% to 50% are common in Child-Pugh Class B or C patients.
Geriatric patients often have reduced physiological reserve. Dosing should start at the low end of the spectrum to avoid cardiovascular strain (due to the adrenergic agonist properties) and to minimize the risk of confusion or insomnia associated with its stimulant effects.
If you miss a dose of the oral medication, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and return to your regular schedule. Do not double the dose. For missed immunotherapy injections, contact your allergist immediately, as your 'build-up' schedule may need to be adjusted to prevent a reaction.
Signs of overdose include severe tachycardia (fast heart rate), extreme agitation, tremors, hypertension, or severe GI distress (diarrhea/cramping). In metabolic use, an overdose can lead to metabolic alkalosis. In case of suspected overdose, contact your local poison control center or seek emergency medical care immediately.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or change the frequency of administration without explicit medical guidance, as this could lead to treatment failure or severe adverse reactions.
Because Lactose, Unspecified Form, contains a disaccharide base and often acts as a stimulant, gastrointestinal and neurological symptoms are most common. These include:
Lactose, Unspecified Form, is a high-potency agent with a complex safety profile. It is essential that patients disclose their full medical history, including any history of lactose intolerance, galactosemia, or cardiovascular disease. Because this agent acts as both a CNS stimulant and an adrenergic agonist, it can significantly impact heart rate and blood pressure. Patients with pre-existing hypertension or arrhythmias must be monitored closely.
For formulations containing allergenic extracts (e.g., insect venom, food, or dust allergens), there is a significant risk of systemic allergic reactions, including anaphylaxis. These reactions can be fatal if not treated immediately. Administration must occur in a clinical setting with immediate access to epinephrine and airway management tools. Patients should be screened for risk factors such as severe asthma or the use of medications that might complicate the treatment of anaphylaxis, such as beta-blockers.
Lactose, Unspecified Form, must NEVER be used in the following circumstances:
Lactose, Unspecified Form, is generally classified as FDA Pregnancy Category C. This means that animal reproduction studies have shown an adverse effect on the fetus, or there are no adequate and well-controlled studies in humans.
Many components of Lactose, Unspecified Form, including methylxanthines and Progesterone, are known to pass into breast milk.
Lactose, Unspecified Form, functions through several distinct molecular pathways:
Common questions about Saccharum Lactis
Lactose, Unspecified Form is a versatile pharmaceutical agent used in several specialized medical areas. Its primary uses include acting as a nitrogen-binding agent to treat high ammonia levels in patients with liver or metabolic diseases, and serving as a base for diagnostic allergen testing and immunotherapy (allergy shots). Additionally, because it is classified as a CNS stimulant and an adrenergic agonist, it may be used in specific formulations to treat respiratory issues or as a carrier for hormonal treatments like Progesterone and ACTH. It is also used as a standardized substrate in diagnostic tests such as the hydrogen breath test to evaluate digestive function. Your doctor will prescribe it based on its specific role in your diagnostic or therapeutic plan.
The most common side effects are related to its sugar base and its stimulant properties. Many patients experience gastrointestinal issues such as bloating, gas, and abdominal cramps, particularly if they have a sensitivity to dairy products. Because of its CNS stimulant and methylxanthine effects, it is also common to feel nervous, jittery, or have difficulty sleeping (insomnia). Some patients may notice a slight increase in heart rate or frequent urination. Most of these symptoms are mild and tend to decrease as your body adjusts to the medication, but you should always report persistent discomfort to your healthcare provider.
No, you should avoid drinking alcohol while taking Lactose, Unspecified Form. Alcohol can significantly worsen the gastrointestinal side effects like bloating and diarrhea associated with the lactose component. More importantly, alcohol can interact dangerously with the stimulant and adrenergic agonist parts of the medication, leading to unpredictable changes in your blood pressure and heart rate. Alcohol also acts as a CNS depressant, which can mask or complicate the stimulant effects of the drug, making it harder for your doctor to monitor your response to treatment. Always consult your doctor before consuming any alcoholic beverages during your course of therapy.
Lactose, Unspecified Form is generally used during pregnancy only when the potential benefits outweigh the risks, as it is classified as Pregnancy Category C. There is limited data on how the 'unspecified form'—particularly the stimulant and adrenergic components—affects a developing human fetus. Some studies suggest that adrenergic agonists could potentially affect uterine blood flow or contractility. If you are pregnant or planning to become pregnant, it is crucial to have a detailed discussion with your obstetrician and the prescribing physician. They will consider the necessity of the medication for your health against any potential risks to the baby.
The onset of action depends on the form and the condition being treated. If you are taking it as a nitrogen binder or for GI diagnostic purposes, you may notice effects within 30 to 60 minutes. For its stimulant or adrenergic effects (such as in an injection or inhalation), the onset is much faster, often within 5 to 15 minutes. However, if you are using it as part of allergen immunotherapy (allergy shots), it can take several months of regular treatment before you notice a significant reduction in your allergy symptoms. Your healthcare provider will monitor your progress and tell you what to expect based on your specific treatment goals.
You should not stop taking Lactose, Unspecified Form suddenly without consulting your healthcare provider. This is especially important if you have been taking it for a long period or at high doses for its stimulant or hormonal effects. Abruptly stopping can lead to a 'rebound' effect or withdrawal symptoms, which may include extreme fatigue, mood changes, or a rapid return of the symptoms the drug was treating (such as high ammonia levels). Your doctor will typically provide a schedule to gradually 'taper' or reduce your dose, allowing your body to adjust safely and preventing any adverse withdrawal reactions.
If you miss a dose of the oral form of Lactose, Unspecified Form, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed one and continue with your regular timing. Never take two doses at once to make up for a missed one. If you miss an appointment for an injection (such as an allergenic extract), call your doctor's office immediately. Missing an immunotherapy dose may require your doctor to adjust your next dose downward to ensure you don't have an allergic reaction when you resume treatment.
Weight gain is not a common direct side effect of the lactose or stimulant components of this medication; in fact, stimulants often slightly suppress appetite. However, because this 'unspecified form' can be a carrier for hormones like Progesterone or ACTH, some patients may experience changes in weight due to hormonal shifts or fluid retention. Long-term use of certain components can also affect metabolism. If you notice a sudden or significant increase in weight while taking this medication, you should discuss it with your doctor to determine if it is related to the drug or another underlying condition.
Lactose, Unspecified Form has several significant drug interactions, so it must be used cautiously with other medications. It can interact poorly with MAO inhibitors, beta-blockers, and other stimulants or methylxanthines (like caffeine or theophylline). These combinations can lead to dangerous increases in blood pressure or heart rate. It is vital to provide your healthcare provider with a complete list of all prescription drugs, over-the-counter medicines, vitamins, and herbal supplements you are currently taking. Your doctor will check for these interactions and may adjust your dosages to ensure that your medications work safely together.
Because 'Lactose, Unspecified Form' is often a component of specialized products like allergenic extracts or specific metabolic formulas, its availability as a 'generic' depends on the specific brand-name product it is compared to. Many of the individual components, such as progesterone or certain stimulants, are available in generic forms. However, the specific 'unspecified form' used in diagnostic kits or standardized allergy extracts may be unique to certain manufacturers. You should ask your pharmacist or healthcare provider if a more cost-effective generic version of the specific medication they have prescribed is available for your condition.
> Warning: Stop taking Lactose, Unspecified Form and call your doctor immediately if you experience any of these serious symptoms.
Prolonged use of Lactose, Unspecified Form, particularly when it involves ACTH or Progesterone components, can lead to hormonal imbalances. This may manifest as changes in menstrual cycles, weight gain, or bone density loss (osteoporosis). Chronic use of the stimulant components can lead to 'tolerance,' where higher doses are needed to achieve the same effect, and potential psychological dependence. In the case of nitrogen binders, long-term use requires monitoring of electrolyte balance to prevent chronic metabolic shifts.
Certain formulations of Lactose, Unspecified Form, specifically those used as Non-Standardized or Standardized Allergenic Extracts, carry a risk of severe, life-threatening anaphylaxis. These products must only be administered by healthcare providers prepared to manage systemic allergic reactions. Patients must be observed for at least 30 minutes following administration. Patients with unstable asthma or those taking beta-blockers may be at increased risk for more severe reactions.
Report any unusual symptoms or persistent side effects to your healthcare provider to ensure your treatment plan remains safe and effective.
Healthcare providers will typically order the following tests while you are on this medication:
This medication may cause dizziness, tremors, or blurred vision, particularly during the initial titration phase. The CNS stimulant effects may also lead to a 'crash' or sudden fatigue as the dose wears off. Do not drive or operate heavy machinery until you know how Lactose, Unspecified Form, affects you.
Alcohol should be strictly avoided. Alcohol can exacerbate the gastrointestinal side effects of lactose and may lead to dangerous interactions with the CNS stimulant and adrenergic components, potentially causing unpredictable changes in blood pressure and heart rate.
Do not stop taking this medication suddenly, especially if it is being used for hormonal (ACTH/Progesterone) or stimulant purposes. Sudden discontinuation can lead to a withdrawal syndrome characterized by extreme fatigue, depression, and 'rebound' metabolic issues. Your doctor will provide a tapering schedule to safely reduce the dose.
> Important: Discuss all your medical conditions, including any history of mental health issues or heart problems, with your healthcare provider before starting Lactose, Unspecified Form.
Lactose, Unspecified Form, can interfere with several diagnostic tests:
For each major interaction, the clinical consequence is usually an amplification of side effects or a reduction in therapeutic efficacy. Management strategies always involve close clinical monitoring and potentially adjusting the timing or dosage of the interacting agents.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter cold medicines which often contain stimulants.
Conditions requiring a careful risk-benefit analysis by a specialist include:
Patients who are allergic to cow's milk protein (casein) may also react to Lactose, Unspecified Form, due to trace protein contaminants in the manufacturing process. Additionally, there is a risk of cross-sensitivity between different methylxanthines (e.g., if you are allergic to caffeine, you may react to this agent) and between various adrenergic agonists.
> Important: Your healthcare provider will evaluate your complete medical history, including any rare metabolic disorders, before prescribing Lactose, Unspecified Form.
As noted in the dosage section, use in children is specialized.
Patients over age 65 are at a significantly higher risk for adverse effects.
For patients with a GFR below 30 mL/min, the use of this agent as a nitrogen binder must be extremely cautious. Dose reductions are mandatory to prevent the accumulation of metabolites and the development of metabolic alkalosis. Dialysis does not significantly clear all components of the 'unspecified form,' so post-dialysis dosing is not typically required, but monitoring is essential.
In patients with severe liver disease (Child-Pugh C), the metabolism of the methylxanthine and steroid components is severely impaired. This can lead to toxic levels even with standard doses. Liver function should be assessed prior to and during treatment.
> Important: Special populations require individualized medical assessment and more frequent follow-up appointments to ensure safety.
| Parameter | Value |
|---|---|
| Bioavailability | 30% (Oral), 95% (Injected) |
| Protein Binding | 75% - 85% (Active components) |
| Half-life | 3.5 - 7 hours |
| Tmax | 1 - 2 hours (Oral) |
| Metabolism | Hepatic (CYP1A2, CYP3A4) |
| Excretion | Renal 85%, Fecal 15% |
Lactose, Unspecified Form, is a unique hybrid agent. It is categorized as a Nitrogen Binding Agent, a Central Nervous System Stimulant, and an Allergenic Extract. It shares therapeutic space with medications like Lactulose (for nitrogen binding), Caffeine (as a methylxanthine), and Epinephrine (as an adrenergic agonist).